Cite
HARVARD Citation
Ndashimye, E. et al. (2020). Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda. Journal of antimicrobial chemotherapy. pp. 3525-3533. [Online].